Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

Effect of Polylactic Acid-Polyglycolic Acid Copolymer/collagen Type Ⅰ Microspheres Combined with BMSCs on Bone Defects in Osteoporotic Rats

Improvement of Intertrochanteric Bone Quality in Osteoporotic Female Rats after Injection of Polylactic Acid-Polyglycolic Acid Copolymer/collagen Type I Microspheres Combined with Bone Mesenchymal Stem Cells

Three-dimensional porous poly(L-lactic acid)/chitosan nanofiber scaffolds combined with bone marrow mesenchymal stem cells in repairing of bone defects

PLGA-BMP-2 and PLA-17β-Estradiol Microspheres Reinforcing a Composite Hydrogel for Bone Regeneration in Osteoporosis

Collagen Nanofilm-Coated Partially Deproteinized Bone Combined With Bone Mesenchymal Stem Cells for Rat Femoral Defect Repair by Bone Tissue Engineering

Injectable nano-hydroxyapatite/chitosan combined with bone marrow stromal cells for repair of bone defects

Three-Dimensional Poly (Epsilon-Caprolactone)/Hydroxyapatite/Collagen Scaffolds Incorporating Bone Marrow Mesenchymal Stem Cells For The Repair Of Bone Defects

Repair of Rat Cranial Bone Defect by Using Bone Morphogenetic Protein-2-related Peptide Combined with Microspheres Composed of Polylactic Acid/polyglycolic Acid Copolymer and Chitosan

Repair of long segment bone defects with a novel bone tissue engineering scaffold beta-tricalcium phosphate/calcium polyphosphate fiber/poly-L-lactic acid composite and bone marrow mesenchymal stem cells

Effect of a Novel Injectable Tissue Engineering Bone with Platelet-Rich Plasma on Bone Regeneration in Vivo

Adoption of Composite Bone Scaffold Loaded with Osteoporosis Drugs in the Repair of Bone Defects in an Osteoporotic Animal Model

Pharmacological Studies on the Composite of CPC/rhBMP-2 Improving the Fracture Healing of Osteoporotic Rats

Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs

Porous bioceramic beta-tricalcium phosphate combined with bone marrow mesenchymal stem cells in the repair of osteonecrosis of the femoral head model: An ultrastructure observation

Repair of Bone Defect in Femoral Condyle Using Microencapsulated Chitosan, Nanohydroxyapatite/Collagen and Poly(L-Lactide)-Based Microsphere-Scaffold Delivery System

The Sequential and Systemic Administration of BMP-2 and SDF-1α Nanocapsules for Promoting Osteoporotic Fracture Healing

Propylene carbonate/chitosan nanofiber porous scaffolds composited with bone marrow mesenchymal stem cell for bone defect repair in rabbits

Poly(DL-lactic-glycolic Acid)/tricalcium Phosphate Scaffolds Loaded with Recombinant Human Bone Morphogenetic Protein-2 Chitosan Microspheres for Treatment of Bone Defects in Rabbits

Treatment of bone defect with osteoblasts transfected by transforming growth factor-beta 1 gene in combination with biomimetic biodegradable polymer scaffolds

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

Combination effect of Chinese kidney-tonifying granules and platelet-rich plasma gels on enhancing bone healing in rat models with femur defects